Improve Research Reproducibility A Bio-protocol resource
- Home
- Protocols
-
Concise Method
Administering of anti-ApoA2 and hIgG to the mice
Ask a
question
Favorite
Starting from the third day after CAWS inoculation, purified Anti-ApoA2 rabbit antibodies (Sigma-Aldrich Inc., St. Louis, MO, USA) and human native immunoglobulin G (hIgG, Nihon Pharmaceutical Co., Ltd., Tokyo Japan) were intraperitoneally administered in the mice for 5 consecutive days,. The dosage of anti-ApoA2 was 0.05, 0.1, and 0.5 mg/kg body weight (kg bw)/day. As a positive control, hIgG was intraperitoneally administered at 0.1 mg/kg bw/day for the 5 consecutive days.
Copyright and License information: The Author(s) ©2022
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Post a Question0 Q&A
